2018
DOI: 10.1096/fasebj.2018.32.1_supplement.571.1
|View full text |Cite
|
Sign up to set email alerts
|

Patient Perceptions of Cholesterol Medications

Abstract: BackgroundCardiovascular disease (CVD) is the leading cause of deaths worldwide. In the majority of patients, CVD is specifically attributed to the development of atherosclerosis primarily caused by elevated plasma cholesterol levels. Statins, HMG‐CoA reductase inhibitors, are the preferential treatment for hypercholesterolemia‐induced cardiovascular‐associated diseases. When taken as prescribed, statins are highly effective in lowering high cholesterol levels, thereby reducing the eventuality of heart attack … Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles